Amalgamated Bank Eli Lilly & CO Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Amalgamated Bank holds 175,260 shares of LLY stock, worth $140 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
175,260
Previous 174,704 0.32%
Holding current value
$140 Million
Previous $158 Million 1.84%
% of portfolio
1.28%
Previous 1.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$772.14 - $960.02 $429,309 - $533,771
556 Added 0.32%
175,260 $155 Million
Q2 2024

Aug 12, 2024
SELL
$724.87 - $909.04 $1.14 Million - $1.43 Million
-1,569 Reduced 0.89%
174,704 $158 Million
Q1 2024

Apr 23, 2024
SELL
$592.2 - $792.28 $15.5 Million - $20.7 Million
-26,108 Reduced 12.9%
176,273 $137 Million
Q4 2023

Feb 06, 2024
SELL
$525.19 - $619.13 $5.84 Million - $6.88 Million
-11,119 Reduced 5.21%
202,381 $118 Million
Q3 2023

Nov 08, 2023
SELL
$434.7 - $599.3 $8.38 Million - $11.6 Million
-19,286 Reduced 8.28%
213,500 $115 Million
Q2 2023

Aug 11, 2023
SELL
$350.74 - $468.98 $1.87 Million - $2.5 Million
-5,341 Reduced 2.24%
232,786 $109 Million
Q1 2023

May 02, 2023
BUY
$310.63 - $364.82 $5.94 Million - $6.97 Million
19,114 Added 8.73%
238,127 $81.8 Million
Q4 2022

Feb 10, 2023
SELL
$321.55 - $374.67 $3.72 Million - $4.34 Million
-11,578 Reduced 5.02%
219,013 $80.1 Million
Q3 2022

Nov 09, 2022
BUY
$296.48 - $337.87 $5.25 Million - $5.99 Million
17,720 Added 8.32%
230,591 $74.6 Million
Q2 2022

Aug 15, 2022
SELL
$278.73 - $327.27 $3.77 Million - $4.43 Million
-13,536 Reduced 5.98%
212,871 $69 Million
Q1 2022

Jun 30, 2022
BUY
$234.69 - $291.66 $1.29 Million - $1.6 Million
5,477 Added 2.48%
226,407 $64.8 Million
Q4 2021

Feb 15, 2022
BUY
$224.85 - $279.04 $7.23 Million - $8.98 Million
32,176 Added 17.05%
220,930 $61 Million
Q3 2021

Oct 29, 2021
SELL
$221.6 - $272.71 $1.92 Million - $2.36 Million
-8,662 Reduced 4.39%
188,754 $43.6 Million
Q2 2021

Aug 16, 2021
BUY
$180.55 - $233.54 $26.4 Million - $34.1 Million
146,177 Added 285.28%
197,416 $45.3 Million
Q1 2021

May 13, 2021
SELL
$164.32 - $212.72 $404,555 - $523,716
-2,462 Reduced 4.58%
51,239 $9.57 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $39,920 - $52,824
-306 Reduced 0.57%
53,701 $9.07 Million
Q3 2020

Oct 30, 2020
SELL
$146.22 - $169.13 $326,070 - $377,159
-2,230 Reduced 3.97%
54,007 $7.99 Million
Q2 2020

Aug 10, 2020
SELL
$136.42 - $164.18 $11.8 Million - $14.1 Million
-86,147 Reduced 60.5%
56,237 $9.23 Million
Q1 2020

May 13, 2020
SELL
$119.05 - $147.35 $460,961 - $570,539
-3,872 Reduced 2.65%
142,384 $19.8 Million
Q4 2019

Feb 13, 2020
BUY
$106.92 - $132.43 $336,798 - $417,154
3,150 Added 2.2%
146,256 $19.2 Million
Q3 2019

Nov 13, 2019
BUY
$106.79 - $116.16 $3.08 Million - $3.35 Million
28,854 Added 25.25%
143,106 $16 Million
Q2 2019

Aug 14, 2019
SELL
$110.79 - $129.32 $1.21 Million - $1.42 Million
-10,951 Reduced 8.75%
114,252 $12.7 Million
Q1 2019

May 15, 2019
SELL
$111.31 - $131.02 $626,118 - $736,987
-5,625 Reduced 4.3%
125,203 $16.2 Million
Q4 2018

Feb 15, 2019
SELL
$105.9 - $118.64 $487,034 - $545,625
-4,599 Reduced 3.4%
130,828 $15.1 Million
Q3 2018

Nov 14, 2018
SELL
$85.86 - $107.31 $424,577 - $530,647
-4,945 Reduced 3.52%
135,427 $14.5 Million
Q2 2018

Jul 18, 2018
SELL
$75.7 - $86.88 $201,210 - $230,927
-2,658 Reduced 1.86%
140,372 $12 Million
Q1 2018

May 22, 2018
BUY
$74.21 - $87.6 $1.04 Million - $1.23 Million
14,002 Added 10.85%
143,030 $11.1 Million
Q4 2017

Feb 13, 2018
BUY
$81.94 - $87.89 $926,905 - $994,211
11,312 Added 9.61%
129,028 $10.9 Million
Q3 2017

Nov 09, 2017
BUY
$77.07 - $85.54 $9.07 Million - $10.1 Million
117,716
117,716 $10.1 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email